Incyte (INCY) Operating Expenses (2010 - 2026)

Incyte (INCY) has 17 years of Operating Expenses data on file, last reported at $976.1 million in Q2 2026.

• Quarterly Operating Expenses rose 42.46% year-over-year to $976.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.0 billion (up 18.79% YoY) and the FY2025 annual result came in at $3.6 billion, down 13.24% from the prior year.
• Operating Expenses held at $976.1 million in Q2 2026, from $971.6 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.5 billion in Q2 2024 to a low of $616.7 million in Q1 2022.
• A 5-year average of $869.1 million and a median of $836.9 million in 2023 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2024 — Operating Expenses soared 100.03% — and 2025, when it sank 54.98%.
• Tracing INCY's Operating Expenses over 5 years: stood at $856.6 million in 2022, then dropped by 3.56% to $826.1 million in 2023, then gained by 6.19% to $877.2 million in 2024, then jumped by 33.49% to $1.2 billion in 2025, then fell by 16.64% to $976.1 million in 2026.
• The last three Operating Expenses figures came in at $976.1 million (Q2 2026), $971.6 million (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.